• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中的心肌缺血和冠状动脉疾病。

Myocardial ischemia and coronary disease in heart failure.

机构信息

Cardio Center, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy.

出版信息

Heart Fail Rev. 2020 Jan;25(1):53-65. doi: 10.1007/s10741-019-09831-z.

DOI:10.1007/s10741-019-09831-z
PMID:31332663
Abstract

Heart failure is a complex clinical syndrome and represents the final path of numerous heart diseases. Coronary artery disease is recognized as the primary risk factor for heart failure development, being the main etiological factor in more than 50% of heart failure patients in North America and Europe. Regardless of overt coronary artery disease, myocardial ischemia is a common finding in failing hearts, likely due to structural or functional coronary circulation alterations. Ischemia is a self-propagating process which irreversibly impairs the cardiac function and negatively impacts prognosis. Thus, a better and thorough understanding of myocardial ischemia pathophysiology in heart failure would likely lead to significantly improved outcomes in these patients. This review aims to describe the mechanisms of myocardial ischemia and coronary artery disease in heart failure, focusing on coronary circulation dysfunctions due to increased parietal stress or non-obstructive coronary disease, and discussing the association and management of coronary artery disease in patients with heart failure.

摘要

心力衰竭是一种复杂的临床综合征,代表了许多心脏病的最终发展路径。冠状动脉疾病被认为是心力衰竭发展的主要危险因素,在北美和欧洲超过 50%的心力衰竭患者中,它是主要的病因。无论是否存在明显的冠状动脉疾病,心肌缺血都是衰竭心脏的常见表现,可能是由于结构性或功能性冠状动脉循环改变所致。缺血是一种自我传播的过程,它会不可逆地损害心脏功能,对预后产生负面影响。因此,更好地、更全面地了解心力衰竭中心肌缺血的病理生理学,可能会显著改善这些患者的结局。本篇综述旨在描述心力衰竭中心肌缺血和冠状动脉疾病的机制,重点讨论由于壁面应力增加或非阻塞性冠状动脉疾病引起的冠状动脉循环功能障碍,并讨论心力衰竭患者的冠状动脉疾病的相关性和管理。

相似文献

1
Myocardial ischemia and coronary disease in heart failure.心力衰竭中的心肌缺血和冠状动脉疾病。
Heart Fail Rev. 2020 Jan;25(1):53-65. doi: 10.1007/s10741-019-09831-z.
2
Pathophysiology of coronary microvascular dysfunction.冠状动脉微血管功能障碍的病理生理学
Vascul Pharmacol. 2023 Dec;153:107239. doi: 10.1016/j.vph.2023.107239. Epub 2023 Oct 28.
3
[Does central vagus tone play a decisive role in myocardial ischemia?].[中枢迷走神经张力在心肌缺血中起决定性作用吗?]
Z Kardiol. 2004 Oct;93(10):765-7. doi: 10.1007/s00392-004-0136-7.
4
Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels.缺血性心脏病和心力衰竭:冠状动脉离子通道的作用。
Int J Mol Sci. 2020 Apr 30;21(9):3167. doi: 10.3390/ijms21093167.
5
Inflammation in Coronary Microvascular Dysfunction.冠状动脉微血管功能障碍中的炎症。
Int J Mol Sci. 2021 Dec 15;22(24):13471. doi: 10.3390/ijms222413471.
6
Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular dysfunction.女性心肌缺血的其他病因:自发性冠状动脉夹层、血管痉挛性心绞痛和冠状动脉微血管功能障碍的最新进展
Vasc Med. 2017 Apr;22(2):146-160. doi: 10.1177/1358863X16686410.
7
Myocardial ischemia is not always due to epicardial atheromatous disease.心肌缺血并不总是由于心外膜动脉粥样硬化疾病引起的。
Clin Cardiol. 2011 Jan;34(1):8-9. doi: 10.1002/clc.20871.
8
Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy.冠状动脉微血管功能障碍与特发性扩张型心肌病。
Pharmacol Rep. 2005;57 Suppl:151-5.
9
Impact of coronary artery tortuosity in ischemic and non-ischemic cardiovascular pathology.冠状动脉迂曲对缺血性和非缺血性心血管病理的影响。
Rom J Intern Med. 2021 May 8;59(2):119-126. doi: 10.2478/rjim-2021-0003. Print 2021 Jun 1.
10
Predicting benefit from revascularization in patients with ischemic heart failure: imaging of myocardial ischemia and viability.预测缺血性心力衰竭患者血运重建的获益:心肌缺血与存活心肌的影像学检查
Circulation. 2011 Feb 1;123(4):444-50. doi: 10.1161/CIRCULATIONAHA.109.903369.

引用本文的文献

1
Sevoflurane Suppresses Cardiomyocyte Pyroptosis in Myocardial Ischemia via NLRP3 Inflammasome Signaling.七氟醚通过NLRP3炎性小体信号通路抑制心肌缺血中的心肌细胞焦亡
Anal Cell Pathol (Amst). 2025 Aug 24;2025:7119597. doi: 10.1155/ancp/7119597. eCollection 2025.
2
Radiomic phenotype of epicardial adipose tissue derived from coronary artery calcium score predicts myocardial ischemia.源自冠状动脉钙化积分的 epicardial 脂肪组织的放射组学表型可预测心肌缺血。
Radiol Med. 2025 Aug 6. doi: 10.1007/s11547-025-02063-2.
3
Machine learning-based predictive modeling of angina pectoris in an elderly community-dwelling population: Results from the PoCOsteo study.

本文引用的文献

1
Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI: Italian Society of Interventional Cardiology Working Group Endorsed by Spanish and Portuguese Interventional Cardiology Societies.经皮左心室辅助支持装置在复杂高危有指征经皮冠状动脉介入治疗中的应用临床专家共识文件:意大利介入心脏病学会工作组认可,西班牙和葡萄牙介入心脏病学会联合发布。
Int J Cardiol. 2019 Oct 15;293:84-90. doi: 10.1016/j.ijcard.2019.05.065. Epub 2019 May 25.
2
Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study.扩张型心肌病的微血管功能障碍:一项定量应激灌注心血管磁共振研究。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1699-1708. doi: 10.1016/j.jcmg.2018.10.032. Epub 2019 Jan 16.
3
基于机器学习的老年社区居住人群心绞痛预测模型:PoCOsteo研究结果
PLoS One. 2025 Aug 5;20(8):e0329023. doi: 10.1371/journal.pone.0329023. eCollection 2025.
4
Evaluation of myocardial fibrosis and wall motion abnormality with Ga-FAPI PET/MR in coronary heart disease.镓标记的纤维连接蛋白激活肽(Ga-FAPI)PET/MR评估冠心病中的心肌纤维化和室壁运动异常
EJNMMI Res. 2025 Jul 21;15(1):89. doi: 10.1186/s13550-025-01246-2.
5
Brain‑heart axis: Neurostimulation techniques in ischemic heart disease (Review).脑-心轴:缺血性心脏病中的神经刺激技术(综述)
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5589. Epub 2025 Jul 19.
6
Dapagliflozin Suppressed Cuproptosis and Myocardial Fibrosis in Myocardial Infarction Through HIF-1α/TGF-β Pathway.达格列净通过HIF-1α/TGF-β途径抑制心肌梗死中的铜死亡和心肌纤维化。
Curr Med Sci. 2025 Jul 7. doi: 10.1007/s11596-025-00076-6.
7
Evaluating the Prognostic Value of Kansas City Cardiomyopathy Questionnaire (KCCQ) Scores for 6-Month Readmissions in Southeast Asian Populations With Heart Failure.评估堪萨斯城心肌病问卷(KCCQ)评分对东南亚心力衰竭患者6个月再入院情况的预后价值。
Clin Cardiol. 2025 Jul;48(7):e70136. doi: 10.1002/clc.70136.
8
Protective mechanism of polysaccharides from Phellinus linteus on H9c2 cardiomyocyte injury induced by hypoxia/reoxygenation.桑黄多糖对缺氧/复氧诱导的H9c2心肌细胞损伤的保护机制
BMC Res Notes. 2025 Jul 1;18(1):263. doi: 10.1186/s13104-025-07308-x.
9
Development and validation of a clinical prediction model for in-hospital heart failure risk following PCI in patients with coronary artery disease.冠心病患者PCI术后院内发生心力衰竭风险的临床预测模型的开发与验证
PLoS One. 2025 Jun 24;20(6):e0325036. doi: 10.1371/journal.pone.0325036. eCollection 2025.
10
Construction and Validation of a Nomogram Model for Predicting Pulmonary Hypertension in Patients with Obstructive Sleep Apnea.阻塞性睡眠呼吸暂停患者肺动脉高压预测列线图模型的构建与验证
Nat Sci Sleep. 2025 May 24;17:1049-1066. doi: 10.2147/NSS.S520758. eCollection 2025.
Absolute Myocardial Blood Flow in Dilated Cardiomyopathy: Does it Matter?扩张型心肌病中的绝对心肌血流量:这重要吗?
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1709-1711. doi: 10.1016/j.jcmg.2018.12.002. Epub 2019 Jan 16.
4
Current Status of Inotropes in Heart Failure.心力衰竭中儿茶酚胺类正性肌力药物的应用现状。
Heart Fail Clin. 2018 Oct;14(4):601-616. doi: 10.1016/j.hfc.2018.06.010. Epub 2018 Aug 17.
5
Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.冠状动脉旁路移植术与经皮冠状动脉介入治疗急性心力衰竭。
Heart. 2020 Jan;106(1):50-57. doi: 10.1136/heartjnl-2018-313242. Epub 2018 Sep 12.
6
Metabolic Modulation of Cardiac Metabolism in Heart Failure.心力衰竭时心脏代谢的代谢调节
Card Fail Rev. 2018 Aug;4(2):99-103. doi: 10.15420/cfr.2018.18.2.
7
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.射血分数保留的心力衰竭中冠状动脉微血管功能障碍的患病率及其相关因素:PROMIS-HFpEF。
Eur Heart J. 2018 Oct 1;39(37):3439-3450. doi: 10.1093/eurheartj/ehy531.
8
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
9
Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.肾素-血管紧张素-醛固酮系统激活在促进心血管纤维化和僵硬中的作用。
Hypertension. 2018 Sep;72(3):537-548. doi: 10.1161/HYPERTENSIONAHA.118.11065.
10
Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.治疗延迟对伴或不伴血液动力学不稳定的 ST 段抬高型心肌梗死(STEMI)患者死亡率的影响:来自德国前瞻性、多中心 FITT-STEMI 试验的结果。
Eur Heart J. 2018 Apr 1;39(13):1065-1074. doi: 10.1093/eurheartj/ehy004.